Cargando…

Application of aptamers for assessment of vaccine efficacy

Assessing antigen concentration of vaccine is essential step in determining the quality of the vaccine prior to vaccination. After vaccination, vaccine-induced antibody titer should also be measured to verify the vaccine efficacy. Since conventional assay used for vaccine concentrations and induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Soo Young, Gee, Grace, Hong, Kee-Jong, Seo, Sang-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540965/
https://www.ncbi.nlm.nih.gov/pubmed/28775981
http://dx.doi.org/10.7774/cevr.2017.6.2.160
_version_ 1783254718794956800
author Yoon, Soo Young
Gee, Grace
Hong, Kee-Jong
Seo, Sang-Hwan
author_facet Yoon, Soo Young
Gee, Grace
Hong, Kee-Jong
Seo, Sang-Hwan
author_sort Yoon, Soo Young
collection PubMed
description Assessing antigen concentration of vaccine is essential step in determining the quality of the vaccine prior to vaccination. After vaccination, vaccine-induced antibody titer should also be measured to verify the vaccine efficacy. Since conventional assay used for vaccine concentrations and induced Ab-titers is antibody-based enzyme-linked immunosorbent assay, the assay inevitably brings drawbacks of antibody such as high cost for production, limited stability, and inconsistent quality between lot-to-lots. Aptamer is single-stranded nucleic acid having three-dimensional structure and has features overcoming limitations of antibody. This review will briefly introduce the features of aptamer and potential of aptamer-based system for evaluation of vaccine efficacy.
format Online
Article
Text
id pubmed-5540965
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Vaccine Society
record_format MEDLINE/PubMed
spelling pubmed-55409652017-08-03 Application of aptamers for assessment of vaccine efficacy Yoon, Soo Young Gee, Grace Hong, Kee-Jong Seo, Sang-Hwan Clin Exp Vaccine Res Brief Communication Assessing antigen concentration of vaccine is essential step in determining the quality of the vaccine prior to vaccination. After vaccination, vaccine-induced antibody titer should also be measured to verify the vaccine efficacy. Since conventional assay used for vaccine concentrations and induced Ab-titers is antibody-based enzyme-linked immunosorbent assay, the assay inevitably brings drawbacks of antibody such as high cost for production, limited stability, and inconsistent quality between lot-to-lots. Aptamer is single-stranded nucleic acid having three-dimensional structure and has features overcoming limitations of antibody. This review will briefly introduce the features of aptamer and potential of aptamer-based system for evaluation of vaccine efficacy. The Korean Vaccine Society 2017-07 2017-07-26 /pmc/articles/PMC5540965/ /pubmed/28775981 http://dx.doi.org/10.7774/cevr.2017.6.2.160 Text en © Korean Vaccine Society. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Yoon, Soo Young
Gee, Grace
Hong, Kee-Jong
Seo, Sang-Hwan
Application of aptamers for assessment of vaccine efficacy
title Application of aptamers for assessment of vaccine efficacy
title_full Application of aptamers for assessment of vaccine efficacy
title_fullStr Application of aptamers for assessment of vaccine efficacy
title_full_unstemmed Application of aptamers for assessment of vaccine efficacy
title_short Application of aptamers for assessment of vaccine efficacy
title_sort application of aptamers for assessment of vaccine efficacy
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540965/
https://www.ncbi.nlm.nih.gov/pubmed/28775981
http://dx.doi.org/10.7774/cevr.2017.6.2.160
work_keys_str_mv AT yoonsooyoung applicationofaptamersforassessmentofvaccineefficacy
AT geegrace applicationofaptamersforassessmentofvaccineefficacy
AT hongkeejong applicationofaptamersforassessmentofvaccineefficacy
AT seosanghwan applicationofaptamersforassessmentofvaccineefficacy